According to a recent market study published by Growth Market Reports titled, “Global Leukocyte Reduction Filter Market By type, end-use category, and region: Size, Share, Trends and Opportunity Analysis, 2017-2027”, the market was valued at USD 4.28 million in 2019 and is expected to grow at a healthy growth rate of 6.1% by the year 2027. In terms of volume, the market is estimated to grow at 5.6% during the forecast period. The global leukocyte reduction filter market is anticipated to grow owing to high prevalence of leukemia, growing awareness about blood donation, and increasing need for platelets and plasma for various medical therapies.

The global leukocyte reduction filter market is fragmented based on type, end-use category, and region. Based on type, the leukocyte reduction filter market has been segmented into whole blood, red blood cell (RBC), platelet, and plasma. By end-use category, the global leukocyte reduction filter market has been categorized into bed side use, laboratory use, and in-line system. Based on region, the global leukocyte reduction filter market is classified into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (LAMEA). North America region is further bifurcated into countries such as U.S., and Canada. Europe is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe, Asia Pacific is further segmented into China, South Korea, Japan, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America is further segmented into Brazil, Mexico, and Rest of Latin America. Middle East & Africa is categorized into Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa.

Request a free sample copy:

In 2020, the sale of leukocyte reduction filters has decreased as compared to that in the year 2019. The COVID-19 pandemic has impacted the medical care among the patients requiring postoperative transfusions as blood donations were limited during lockdowns across the globe. The reduction in the number of blood donations has negatively impacted the demand for leukocyte reduction filters across the globe. Moreover, due to the COVID-19 outbreak, the surgical procedures are postponed except emergency and essential surgeries. Thus, the reduction in postoperative transfusions has hampered the demand for leukocyte reduction filter in 2020.

As per Growth Market Reports industry analyst Akshata Ahire, “The Global Leukocyte Reduction Filter Market is anticipated to witness significant growth during forecast period 2020-2027 driven by the increasing demand for plasma and platelets across the globe. Increasing demand for platelets and plasma for the treatment of life-threatening diseases and deficiencies such as hemophilia, thrombocytopenia, coagulation factor deficiencies, liver disease and other blood disorders is projected to boost the demand for leukocyte reduction filter across the globe. Moreover, increasing awareness regarding blood donations increases the demand for leukocyte reduction filter. Furthermore, increasing investments and developments in the life science industry are expected to boost the number of people availing for medical services, thus creating opportunities in the leukocyte reduction filter market.

Key Takeaways from the Study

  • The companies such as Haemonetics Corporation, TERUMO BCT, INC., and Guangzhou Daji Medical Science and Technology Co., Ltd. held approximately one fifth of the market share of global leukocyte reduction filter market in year 2019.
  • North America accounts for a major share of the market, followed by Asia Pacific. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period.
  • The bed side use segment is anticipated to expand at a moderate CAGR during the forecast period owing to the increasing need of transfusion in hospitals and emergency rooms during surgical procedures as well as various medical treatments.
  • Asia Pacific is expected to expand at the highest CAGR owing to the growing population in developing countries, such as China and India. Factors such as increasing government investments in healthcare and rising awareness programs related to blood donations are expected to contribute to the market growth.

Report Scope

Report Metric


Market Value in 2019

USD 4.28 million

Market Growth Rate (from 2020 to 2027)


Historical Data

2017 & 2018

Base Year


Forecast Period

2020 - 2027

Units Considered

Value (USD Million) & Volume (Mn Units)

Market Segments

Type, End-Use Category

Regional Scope

North America, Europe, Asia Pacific, Latin America and Middle East & Africa (LAMEA)

Country Scope

U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, Japan, India, Australia, South Korea, South East Asia, Brazil, Mexico, Saudi Arabia, South Africa, UAE

Key Companies Profiled

Haemonetics Corporation, TERUMO BCT, INC., Guangzhou Daji Medical Science and Technology Co., Ltd., Mitra Industries (P) Ltd., Kawasumi Laboratories, Inc., Nanjing Shuangwei Biotechnology Co., Ltd., PURIBLOOD MEDICAL CO., LTD., Bıçakcılar, Shandong Zhongbaokang Medical Implements Co., Ltd., Fresenius Kabi AG, Macopharma, Asahi Kasei Medical Co., Ltd., NPP Interoko (

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements.

Target Audience

  • Supply-side: Leukocyte reduction filter manufacturers, blood filter manufacturers, raw material suppliers, primary respondents, and distributors.
  • Demand Side: Laboratories, hospitals, and blood centers
  • Regulatory Side: Concerned government authorities, commercial research & development (R&D) institutions, and other regulatory bodies.
  • Associations and Industry Bodies: International Society of Blood Transfusion, The Indian Society of Blood Transfusion & Immunohaematology (ISBTI), Africa Society for Blood Transfusion (AfSBT), European Blood Alliance, International Consortium for Blood Safety (ICBS), The South Asian Association of Transfusion Medicine (SAATM), World Federation of Hemophilia (WFH)